Genetic and familial factors influencing breast, colon, prostate and lung cancers
- PMID: 20397487
Genetic and familial factors influencing breast, colon, prostate and lung cancers
Abstract
Knowledge of cancer genetics is advancing our biological understanding of breast, colon, prostate and lung cancers. A family history of any one of these four types of cancer can increase an individual's personal risk to also develop a malignancy. For some families, genetic testing, in combination with genetic counseling, can be a helpful way to identify a hereditary cancer predisposition gene or establish a cancer risk management plan. In this paper, we will review the current state of knowledge surrounding genetic factors influencing breast, colon, prostate and lung cancer.
Similar articles
-
Evaluation of bias in familial risk estimates: a study of common cancers using Swedish population-based registers.J Natl Cancer Inst. 2008 Sep 17;100(18):1318-25. doi: 10.1093/jnci/djn290. Epub 2008 Sep 9. J Natl Cancer Inst. 2008. PMID: 18780865
-
American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.J Clin Oncol. 2003 Jun 15;21(12):2397-406. doi: 10.1200/JCO.2003.03.189. Epub 2003 Apr 11. J Clin Oncol. 2003. PMID: 12692171
-
Inherited susceptibility to common cancers.N Engl J Med. 2008 Nov 13;359(20):2143-53. doi: 10.1056/NEJMra0802968. N Engl J Med. 2008. PMID: 19005198 Review. No abstract available.
-
A social network analysis of communication about hereditary nonpolyposis colorectal cancer genetic testing and family functioning.Cancer Epidemiol Biomarkers Prev. 2003 Apr;12(4):304-13. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 12692104
-
Cancer genetics in primary care.Prim Care. 2004 Sep;31(3):649-83, xi. doi: 10.1016/j.pop.2004.05.001. Prim Care. 2004. PMID: 15331253 Review.
Cited by
-
Familial diabetes is associated with reduced risk of cancer in diabetic patients: a possible role for metformin.Med Oncol. 2012 Jun;29(2):1308-13. doi: 10.1007/s12032-011-9840-0. Epub 2011 Feb 6. Med Oncol. 2012. PMID: 21298495
-
Effect of CYP17 and PSA gene polymorphisms on prostate cancer risk and circulating PSA levels in the Slovak population.Mol Biol Rep. 2012 Aug;39(8):7871-80. doi: 10.1007/s11033-012-1631-y. Epub 2012 Apr 22. Mol Biol Rep. 2012. PMID: 22528335
-
Is XMRV a causal virus for prostate cancer?Asian J Androl. 2011 Sep;13(5):698-701. doi: 10.1038/aja.2011.32. Epub 2011 Jul 18. Asian J Androl. 2011. PMID: 21765437 Free PMC article. Review.
-
Association of CYP1A1 rs1048943 Polymorphism with Prostate Cancer in Iraqi Men Patients.Asian Pac J Cancer Prev. 2019 Dec 1;20(12):3839-3842. doi: 10.31557/APJCP.2019.20.12.3839. Asian Pac J Cancer Prev. 2019. PMID: 31870130 Free PMC article.
-
Associations of CYP1 polymorphisms with risk of prostate cancer: an updated meta-analysis.Biosci Rep. 2019 Mar 1;39(3):BSR20181876. doi: 10.1042/BSR20181876. Print 2019 Mar 29. Biosci Rep. 2019. PMID: 30765615 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical